Palvella Therapeutics (PVLA) Net Margin Growth (1y) (2015 - 2024)
Palvella Therapeutics (PVLA) Net Margin Growth (1y) (2015 - 2024) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Margin Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 1,491.00 |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 1,120.00 |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | -653.00 |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 447.00 |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | - |
| 10 | Palvella Therapeutics | 318.78 Mn | 56.92 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2024 | -435,438.00 |
| Dec 31, 2023 | 845,676.00 |
| Sep 30, 2023 | 484,703.00 |
| Jun 30, 2023 | 562,953.00 |
| Mar 31, 2023 | -72,324.00 |
| Dec 31, 2022 | -885,341.00 |
| Sep 30, 2022 | -442,667.00 |
| Jun 30, 2022 | -329,140.00 |
| Mar 31, 2022 | -2,903.00 |
| Dec 31, 2021 | -50,946.00 |
| Sep 30, 2021 | 4,409.00 |
| Jun 30, 2021 | -228,226.00 |
| Mar 31, 2021 | -1,296.00 |
| Dec 31, 2020 | 37,536.00 |
| Sep 30, 2020 | -51,037.00 |
| Jun 30, 2020 | 17,244.00 |
| Mar 31, 2020 | 8,976.00 |
| Dec 31, 2019 | 194,254.00 |
| Sep 30, 2019 | 5,660.00 |
| Jun 30, 2019 | -21,878.00 |